The New Antifungal Toolkit: The Pharmacopeia and Beyond

The New Antifungal Toolkit: The Pharmacopeia and Beyond is an Internet CME curriculum that will provide current information about new FDA-approved agents/formulations for the management of invasive fungal infections (IFIs) and evaluate the role of these newer options in strategies to optimize antifungal therapy. As such, the activity will move beyond the typical drug pharmacopeia to address dosing in special populations (eg, pediatrics, patients with renal insufficiency, specific host types), health economic data, as well as comparative effectiveness, where appropriate. The activity will also include a broader pharmacopeia of all FDA-approved agents for invasive mycoses as a useful point of comparison as well as a practice reference. Two updates cover additional FDA approvals and keep the learner up to date as research data for newer agents mature and clinical experience grows.